• Mashup Score: 0
    AAD.org Login - 7 month(s) ago

    Create a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our

    Source: identity.aad.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      TAKE ACTION! 📣 Tell the FDA to make vital changes to #iPLEDGE program now. Use the Academy's template letter to contact the FDA with a personalized story about why this issue matters to you and your patients. https://t.co/yBPnPnbn6b https://t.co/Exsy0eOsai

  • Mashup Score: 0
    AAD.org Login - 7 month(s) ago

    Create a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our

    Source: identity.aad.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      TAKE ACTION! 📣 Tell the FDA to make vital changes to #iPLEDGE program now. Use the Academy's template letter to contact the FDA with a personalized story about why this issue matters to you and your patients. https://t.co/yBPnPnbn6b https://t.co/JLxsZTzSwL

  • Mashup Score: 0
    AADA Advocacy Update - 1 year(s) ago

    AADA hosts annual Capitol Hill Skin Cancer Screening event On May 10, the AADA, in conjunction with the Congressional Skin Cancer Caucus, held its Annual Congressional Skin Cancer Screening and Health Fair, which offered free skin cancer screenings to Members of Congress, staff, and the public. Over 120 attended the event. In addition, 11 AADA physician members volunteered their time to…

    Source: email.aadcommunications.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      Through AADA’s tireless advocacy, the @US_FDA is extending approval of at-home pregnancy tests under #iPLEDGE Risk Evaluation and Mitigation Strategy. The FDA extended certain COVID-19-related flexibilities through fall of 2023, including pregnancy tests. https://t.co/av1jSQ30Ho https://t.co/KplXqce54X

  • Mashup Score: 2
    iPLEDGE win included in year-end package - 1 year(s) ago

    The AADA’s 2022 advocacy efforts were successful in securing provisions on the iPLEDGE Program within the omnibus spending package that was signed into law in December 2022.

    Source: www.aad.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      Following the #iPLEDGE crisis in 2021 and early 2022, the AADA worked to develop legislative language with the goal of protecting against such a crisis occurring in the future. Language the AADA championed will require the FDA to provide a public comment...https://t.co/sw1kwit2Xc https://t.co/TCGJ9OTefk

  • Mashup Score: 4
    iPLEDGE advocacy brings new opportunities for long-term change - 2 year(s) ago

    Dear Colleagues: Today, we met with the FDA, the Isotretinoin Product Manufacturers Group (IPMG), pharmacists, and other relevant stakeholders to continue our discussions on the significant issues with the iPLEDGE program. During this joint stakeholder meeting, the IPMG shared that some issues with the iPLEDGE program have been addressed, but there is still ongoing improvement….

    Source: email.aadresources.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      Yesterday, we met with the @US_FDA, the Isotretinoin Product Manufacturers Group (IPMG), pharmacists, and other relevant stakeholders to continue our discussions on the significant issues with the #iPLEDGE program. Learn more from Dr. Bruce Brod @BABROD - https://t.co/SSFA7XQH8t

  • Mashup Score: 6
    Nearly Two-Thirds Still Locked Out of iPLEDGE - 2 year(s) ago

    A survey conducted by Dermatology Times® found that many still cannot access the iPLEDGE system. Now some have created guides to get around the issue.

    Source: Dermatology Times
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DermTimesNow
      DermTimesNow

      A survey conducted by Dermatology Times® found that many still cannot access the #iPLEDGE system. Now some have created guides to get around the issue. https://t.co/kQB2wJkFrK

  • Mashup Score: 2
    AADA meets with IPMG, calls for multi-pronged solution - 2 year(s) ago

    Dear Colleagues: Throughout the holidays, the American Academy of Dermatology Association (AADA) has continued to pressure the iPLEDGE Product Manufacturers Group (IPMG) to halt the program, fix its platform, or find reasonable workarounds to restore patient access to isotretinoin. On December 30, members of the AADA iPLEDGE Workgroup were invited to meet with members of the IPMG, who were…

    Source: email.aadresources.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AADmember
      AADmember

      The AADA continues to pressure the #iPLEDGE Product Manufacturers Group (IPMG) to halt the program, fix its platform, or find reasonable workarounds to restore patient access to isotretinoin. Learn more, plus how how patients can submit their stories. https://t.co/oCVE8Bvkz4

Load More